Cargando...

Autonomic effects of selegiline: possible cardiovascular toxicity in Parkinson's disease

OBJECTIVES—The United Kingdom Parkinson's Disease Research Group (UKPDRG) trial found an increased mortality in patients with Parkinson's disease randomised to receive selegiline (10 mg/day) and levodopa compared with those taking levodopa alone. Unwanted effects of selegiline on cardiovas...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Churchyard, A, Mathias, C, Boonkongchuen, P, Lees, A
Formato: Artigo
Idioma:Inglês
Publicado: BMJ Group 1997
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC2169684/
https://ncbi.nlm.nih.gov/pubmed/9285463
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!